While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

it was not possible to evaluate the risk of arthritis in ACPA-positive and/or IgM-RF−positive subjects compared with those presenting with seronegative arthralgia.” ...